Refine by MP, party, committee, province, or result type.

Results 1-11 of 11
Sorted by relevance | Sort by date: newest first / oldest first

Finance committee  I think the creation of the Canadian Alzheimer's disease and dementia partnership is the primary vehicle to move forward and improve research, but also to improve workplace education and improve the support offered through the First Link program. I think all of those together co

September 30th, 2014Committee meeting

Jim Mann

Finance committee  I think you're right that the need is there. As I had agreed earlier, with so much different research going on, or so many people doing the research, there's a need to coordinate. If you have a group of people doing biomedical research, then you're hoping that scientist A will no

September 30th, 2014Committee meeting

Jim Mann

Finance committee  Not specifically, Mr. Brison. I'm not entirely sure. Sorry.

September 30th, 2014Committee meeting

Jim Mann

Finance committee  The major one is setting up the Canadian Alzheimer's disease and dementia partnership, along the lines of the Canadian Partnership Against Cancer and the Mental Health Commission. I think the results of the Partnership Against Cancer, for one, show very clearly the progress that

September 30th, 2014Committee meeting

Jim Mann

Finance committee  I'm sorry. Could you ask the question again for me?

September 30th, 2014Committee meeting

Jim Mann

Finance committee  Just the last part. I forgot.

September 30th, 2014Committee meeting

Jim Mann

Finance committee  I think it's fair to say that the problems we have with the numbers of people being diagnosed with dementia and their families.... That number is increasing all the time. As for the experience with the Canadian Partnership Against Cancer and the Mental Health Commission, both of

September 30th, 2014Committee meeting

Jim Mann

Finance committee  First of all, the Alzheimer Society of Canada has a research program that it runs, and it has distributed many millions of dollars to many different Canadian researchers, in both biomedical and quality-of-life streams. That is one area where we are working with many different res

September 30th, 2014Committee meeting

Jim Mann

Finance committee  Good afternoon, Mr. Chair and members. Thank you for giving me this opportunity to speak with you today about Alzheimer's disease. It's an issue that's very important to me and to hundreds of thousands of families across Canada. But first, Mr. Chair, I would like to thank you an

September 30th, 2014Committee meeting

Jim Mann

Subcommittee on Neurological Disease committee  I shared the stage a year or two ago with a few people. There was a couple on the stage. One was a person with Alzheimer's and the other was his caregiver wife. They were relatively new to the city where they were living, having moved from back east, and didn't really have a lot

December 7th, 2010Committee meeting

Jim Mann

Subcommittee on Neurological Disease committee  Thank you, Madam Chair and members of this subcommittee, for holding hearings on this important topic, Alzheimer's and dementia. With the increasing prevalence of dementia in Canada and the impact on families, employers, and the economy, as detailed in the Rising Tide report, th

December 7th, 2010Committee meeting

Jim Mann